Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
Research output: Contribution to journal › Journal article › Research › peer-review
Patients with atrial fibrillation (AF) often require anticoagulation and platelet inhibition, but data are limited on the bleeding risk of combination therapy.
| Original language | English |
|---|---|
| Journal | Archives of Internal Medicine |
| Volume | 170 |
| Issue number | 16 |
| Pages (from-to) | 1433-41 |
| Number of pages | 9 |
| ISSN | 0003-9926 |
| DOIs | |
| Publication status | Published - 13 Sep 2010 |
ID: 34044217